Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Peringkat dalam Saham
#4850
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Harga Saham
$2.55
Kapitalisasi Pasar
$3.05B
Perubahan (1 hari)
3.33%
Perubahan (1 tahun)
-11.84%
Negara
CN
Perdagangan Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategori
Healthcare
Jumlah saham beredar untuk Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Jumlah saham beredar per June 2026: 1.17B
Menurut laporan keuangan terbaru dan harga saham Jilin Aodong Pharmaceutical Group Co., Ltd., jumlah saham beredar saat ini adalah 1.17B. Pada akhir December 2023, perusahaan memiliki 1.13B saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Jilin Aodong Pharmaceutical Group Co., Ltd. (000623) dari 2000 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 1.17B | -0.40% |
| 2024 | 1.18B | 4.59% |
| 2023 | 1.13B | -0.81% |
| 2022 | 1.13B | -0.41% |
| 2021 | 1.14B | -1.63% |
| 2020 | 1.16B | -0.40% |
| 2019 | 1.16B | 0.02% |
| 2018 | 1.16B | 0.00% |
| 2017 | 1.16B | 1.31% |
| 2016 | 1.15B | -1.28% |
| 2015 | 1.16B | 0.17% |
| 2014 | 1.16B | -0.49% |
| 2013 | 1.17B | -0.06% |
| 2012 | 1.17B | 0.56% |
| 2011 | 1.16B | -0.12% |
| 2010 | 1.16B | -0.20% |
| 2009 | 1.16B | -0.04% |
| 2008 | 1.16B | 0.05% |
| 2007 | 1.16B | 0.20% |
| 2006 | 1.16B | -0.20% |
| 2005 | 1.16B | 0.00% |
| 2004 | 1.16B | 0.00% |
| 2003 | 1.16B | 0.00% |
| 2002 | 1.16B | 0.00% |
| 2001 | 1.16B | 0.00% |
| 2000 | 1.16B | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 104.65% |
IN
|
